Image

Implementation ofMOVEMENT CONTROL ORDER (MCO)CONDITIONAL MOVEMENT CONTROL ORDER (CMCO)RECOVERY MOVEMENT CONTROL ORDER (RMCO)at NPRA


Kindly be informed National Regulatory Pharmaceutical Agency (NPRA) has resumed normal operation on premise beginning 13 May 2020.

Practice social distancing at all times and kindly be advised to physically be present on site only when necessary.


FAQ: Hand Sanitizers

FAQ: Hand Sanitizers

Cosmetics Section's compilation of Frequently Asked Questions regarding hand sanitizers.

Official Notice for Site Inspections

Temporary Suspension for Site Inspections

Official notice for temporary suspension for inspection in and out of Malaysia for GMP, GDP, GCP and GLP and BE Research Centers.

FAQ: GMP & GDP Inspections

FAQ: GMP & GDP Inspections

FREQUENTLY ASKED QUESTIONS ON GOOD MANUFACTURING PRACTICE (GMP) AND GOOD DISTRIBUTION PRACTICE (GDP) INSPECTIONS BY NATIONAL PAHARMACEUTICAL REGULATORY AGENCY (NPRA) DURING COVID-19 PANDEMIC

 

FAQ: Clinical Trials

FAQ: Clinical Trial

Guidance from Evaluation and Safety of Investigational Product Section on Managing Clinical Trials during the Covid-19 Pandemic in Malaysia.

Reporting ADR (including drugs used for COVID-19 treatment)


Please report ALL suspected Adverse Drug Reactions (ADRs) to the National Centre for Adverse Drug Reactions Monitoring.
Click for more info.

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 17 September 2020, 12:28:54.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language